Progress in Treatments for NSCLC Patients with METex14 Mutations
Abnormalities in the MET gene have been shown to be key drivers in the development and growth of non-small cell lung cancer (NSCLC). These MET abnormalities frequently occur as
Abnormalities in the MET gene have been shown to be key drivers in the development and growth of non-small cell lung cancer (NSCLC). These MET abnormalities frequently occur as
Lung cancer continues to be the leading cause of cancer deaths in the United States and worldwide. Because cancer treatments are most effective when the cancer is caught early
Checkpoint blockade immunotherapy uses drugs to take the brakes off a patient’s immune system so that the immune cells can then recognize and attack tumor cells. However, the
Researchers continue to improve outcomes for patients with non-small cell lung cancer (NSCLC) by learning more about the disease and how it interacts with our immune system
Biomarker testing is the first step in precision medicine—ensuring that a patient gets matched to the right treatment at the right time, based on their biomarker status. Treatment
Small cell lung cancer accounts for approximately 15 percent of all lung cancer diagnoses. It is found most often in patients with a substantial history of tobacco exposure. Small
Spring is here, and with that comes a lot of new seasonal fruits and veggies to add to your repertoire! We’ve taken the opportunity to give you some general tips on how to maximize
In the past decade, researchers have identified many types of lung cancer, including ALK-positive lung cancer, a subset of non-small cell lung cancer (NSCLC) resulting from the
Pathologists are charged with the task of studying biopsy samples from patients to diagnose disease and to aid in disease management. While lung cancer pathology is becoming
Welcome to a new decade! While now is about the time most people give up on “New Year’s Resolutions,” there is no reason you can’t stick to the goals you made earlier this month
Some lung cancer patients respond well to treatment with checkpoint inhibitor immunotherapy, which allows the body’s immune system to identify and attack cancer cells. However